E250 - Follow the Money - Mads Daugaard, How to Build a BioTech Company
“I would say [biotech is] definitely more risky than commodities or other areas to invest in. But the reward is also substantially higher.”
Investing in biotech can be a risky proposition - often requiring significant sunk costs in research and development with no guarantee of success. Many scientists also struggle to commercialize their discoveries, failing to adequately protect them through intellectual property and patents. However, those who are able to navigate these challenges and successfully move their inventions from research publications to the marketplace can reap tremendous rewards. Discover the opportunities available in Alberta and Canada for becoming a world leader in biotech investment.